Eyebright Medical Technology (Beijing) Co Ltd. Stock Analysis 688050.SS

Eyebright Medical Technology (Beijing) Co., Ltd. engages in the research and development, production, sales and related services of ophthalmic medical equipment and devices. The company is headquartered in Beijing, Beijing and currently employs 2,331 full-time employees. The company went IPO on 2020-07-29. The firm's products cover three major areas: ophthalmic surgical treatment, myopia prevention and control, and vision health care. The surgical treatment products mainly include the series of basic and functional artificial intraocular lenses such as Proming and Quanshi. The myopia prevention and control products mainly include iBright brand corneal reshaping lenses, as well as defocusing frame lenses, defocusing soft lenses, and daily rigid contact lenses. The vision health products mainly include transparent contact lenses and colored contact lenses from brands such as Lebleu, Ocula, and TOPPOP.